|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59 TWD | -1.83% |
|
-2.64% | +65.27% |
| 15/05 | Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 14/03 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mycenax Biotech Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 80.19 million compared to TWD 138.39 million a year ago. Net loss was TWD 135.61 million compared to TWD 240.97 million a year ago.
Basic loss per share from continuing operations was TWD 0.66 compared to TWD 1.17 a year ago. Diluted loss per share from continuing operations was TWD 0.66 compared to TWD 1.17 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +65.27% | 37Cr | |
| +15.20% | 12TCr | |
| +19.67% | 11TCr | |
| +18.95% | 2.6TCr | |
| -23.86% | 1.94TCr | |
| -19.03% | 1.59TCr | |
| -20.90% | 1.51TCr | |
| -46.14% | 1.51TCr | |
| +63.85% | 1.49TCr | |
| +4.49% | 1.39TCr |
MYCENAX BIOTECH INC. 
